Niagen Net Interest Income from 2010 to 2026
| NAGE Stock | 6.52 0.04 0.61% |
Net Interest Income | First Reported 2010-12-31 | Previous Quarter 1.3 M | Current Value 1.4 M | Quarterly Volatility 527.1 K |
Check Niagen Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Niagen Bioscience's main balance sheet or income statement drivers, such as Other Operating Expenses of 110.9 M, Operating Income of 7.3 M or EBITDA of 8.7 M, as well as many indicators such as Price To Sales Ratio of 6.59, Dividend Yield of 0.0 or PTB Ratio of 10.75. Niagen financial statements analysis is a perfect complement when working with Niagen Bioscience Valuation or Volatility modules.
Niagen | Net Interest Income | Build AI portfolio with Niagen Stock |
Latest Niagen Bioscience's Net Interest Income Growth Pattern
Below is the plot of the Net Interest Income of Niagen Bioscience over the last few years. It is the difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities. Niagen Bioscience's Net Interest Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Niagen Bioscience's overall financial position and show how it may be relating to other accounts over time.
| Net Interest Income | 10 Years Trend |
|
Net Interest Income |
| Timeline |
Niagen Net Interest Income Regression Statistics
| Arithmetic Mean | 223,213 | |
| Geometric Mean | 93,229 | |
| Coefficient Of Variation | 236.14 | |
| Mean Deviation | 418,678 | |
| Median | (55,000) | |
| Standard Deviation | 527,084 | |
| Sample Variance | 277.8B | |
| Range | 1.4M | |
| R-Value | 0.75 | |
| Mean Square Error | 131.8B | |
| R-Squared | 0.56 | |
| Significance | 0.0006 | |
| Slope | 77,783 | |
| Total Sum of Squares | 4.4T |
Niagen Net Interest Income History
About Niagen Bioscience Financial Statements
Niagen Bioscience stakeholders use historical fundamental indicators, such as Niagen Bioscience's Net Interest Income, to determine how well the company is positioned to perform in the future. Although Niagen Bioscience investors may analyze each financial statement separately, they are all interrelated. For example, changes in Niagen Bioscience's assets and liabilities are reflected in the revenues and expenses on Niagen Bioscience's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Niagen Bioscience. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Net Interest Income | 1.3 M | 1.4 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Niagen Bioscience is a strong investment it is important to analyze Niagen Bioscience's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Niagen Bioscience's future performance. For an informed investment choice regarding Niagen Stock, refer to the following important reports:Check out the analysis of Niagen Bioscience Correlation against competitors. For information on how to trade Niagen Stock refer to our How to Trade Niagen Stock guide.You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Niagen Bioscience. If investors know Niagen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Niagen Bioscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 1.5 | Earnings Share 0.24 | Revenue Per Share | Quarterly Revenue Growth 0.329 | Return On Assets |
The market value of Niagen Bioscience is measured differently than its book value, which is the value of Niagen that is recorded on the company's balance sheet. Investors also form their own opinion of Niagen Bioscience's value that differs from its market value or its book value, called intrinsic value, which is Niagen Bioscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Niagen Bioscience's market value can be influenced by many factors that don't directly affect Niagen Bioscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Niagen Bioscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Niagen Bioscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Niagen Bioscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.